MIT Technology Review names nine under-35 biotech innovators in 35 Innovators Under 35 list

MIT Technology Review today names nine under-35 innovators shaping the future of biotech as part of its annual 35 Innovators Under 35 list. The cohort highlights emerging advances across gene editing, synthetic biology, diagnostics, and therapeutics, fields drawing fresh capital and policy attention. The list often signals where research funding, talent, and startup activity are headed next for the sector.

According to MIT Technology Review, the biotech honorees span academic labs and startups of varying sizes, reflecting progress from bench research to clinical translation and manufacturing. Past editions over the past decade have raised the profile of young researchers and founders as the outlet publishes detailed profiles alongside the wider 35 Innovators Under 35 rollout. Watch for investor and industry reactions, and whether featured teams announce new funding, partnerships, or trial milestones in the coming days. [Developing. This article will be updated.]